StockData
Enveric Biosciences, Inc. logo

Enveric Biosciences, Inc. (ENVB) income statement

ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.42+0.01 (+0.71%)

Close on Nov 18, 2026Market cap $6.36MP/E –Yield –

See a number that looks wrong?